The global CT and MRI contrast agents market was valued at USD 5.98 billion in 2023 and is projected to grow to USD 6.47 billion in 2024, reaching USD 11.59 billion by 2031, with a CAGR of 8.70% during the forecast period. This growth is driven by ongoing advancements in medical imaging technologies, which are improving the accuracy, efficiency, and effectiveness of diagnostic procedures across...